2022年

Nakayama Y, Mizuno H, Sawa N, Suwabe T, Yamanouchi M, Ikuma D, Hasegawa E, Hoshino J, Sekine A, Oba Y, Kono K, Kinowaki K, Ohashi K, Suzuki K, Sato Y, Shimizu A, Yamaguchi Y, Ubara Y. A Case of Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions. Intern Med. 2022 Dec 14. doi: 10.2169/internalmedicine.0529-22.

Hirami Y, Nishimura MF, Urata T, Morimoto M, Maekawa Y, Yoshino T, Nishimura Y, Sato Y. Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma. J Clin Exp Hematop. 2022 in press.

Kawanishi M, Kamei F, Sonoda H, Oba M, Fukunaga S, Egawa M, Koyama T, Sato Y, Tanabe K, Ito T. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease. CEN Case Rep. 2022 Nov 21. doi: 10.1007/s13730-022-00751-w.

Liu W, Cai Q, Yu T, Strati P, Hagemeister FB, Zhai Q, Zhang M, Li L, Fang X, Li J, Sun R, Zhang S, Yang H, Wang Z, Qian W, Iwaki N, Sato Y, Oksenhendler E, Xu-Monette ZY, Young KH, Yu L. Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up. Am J Cancer Res. 2022; 12 (9): 4227-4240.

Nishikori A, Nishimura MF, Nishimura Y, Otsuka F, Maehama K, Ohsawa K, Momose S, Nakamura N, Sato Y. Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease. Int J Mol Sci. 2022; 23(18): 10301.　【Q1】

Itano J, Taniguchi A, Senoo S, Asada N, Gion Y, Egusa Y, Guo L, Oda N, Araki K, Sato Y, Toyooka S, Kiura K, Maeda Y, Miyahara N. Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis Through IL-1β Inhibition. Am J Respir Cell Mol Biol. 2022 Sep 19. doi: 10.1165/rcmb.2021-0542OC.

Sawada H, Czech T, Silangcruz K, Kozai L, Obeidat A, Wien EA, Nishimura MF, Nishikori A, Sato Y, Nishimura Y. Clinicopathological Characteristics of Gastric IgG4-related Disease: Systematic Scoping Review. J Gastroenterol Hepatol. 2022; 37(10): 1865-1872.

Shiraiwa S, Kikuti YY, Carreras J, Kondo Y, Ohmachi K, Ogawa Y, Kawada H, Sato S, Gion Y, Sato Y, Nakamura N, Ando K. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions. Am J Surg Pathol. 2022 Aug 1; 46(8):1017-1024. doi: 10.1097/PAS.0000000000001899.

Nishimura Y, Wien EA, Nishimura MF, Nishikori A, Sato Y, Otsuka F. Clinical characteristics and outcomes of IgG4-positive marginal zone lymphoma: Systematic scoping review. Pathol Int. 2022 Jun 9. doi: 10.1111/pin.13251.

Nishimura Y, Nishimura MF, Fajgenbaum DC, van Rhee F, Sato Y, Otsuka F. Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis. eJHaem. 2022;1–6. DOI: 10.1002/jha2.459

Munemura R, Maehara T, Murakami Y, Koga R, Aoyagi R, Kaneko N, Doi A, Perugino CA, Della-Torre E, Saeki T, Sato Y, Yamamoto H, Kiyoshima T, Stone JH, Pillai S, Nakamura S. Distinct disease-specific Tfh cell populations in two different fibrotic diseases: IgG4-related disease and Kimura's disease. J Allergy Clin Immunol. 2022 May 11:S0091-6749(22)00622-4. doi: 10.1016/j.jaci.2022.03.034.

Nishimura MF, Nishimura Y, Nishikori A, Yoshino T, Sato Y. Historical and pathological overview of Castleman disease. J Clin Exp Hematop. 2022 Apr 27. doi: 10.3960/jslrt.21036.

Nishimura Y, Nishimura MF, Sato Y. International definition of iMCD-TAFRO: future perspectives. J Clin Exp Hematop. 2022 Apr 27. doi: 10.3960/jslrt.21037.

Nishimura Y, Nishikori A, Sawada H, Czech T, Otsuka Y, Nishimura MF, Mizuno H, Sawa N, Momose S, Ohsawa K, Otsuka F, Sato Y. Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease ?  J Clin Exp Hematop. 2022 Mar 5. doi: 10.3960/jslrt.21038.

Naoi Y, Tachibana T, Wani Y, Hotta M, Haruna K, Komatsubara Y, Kuroda K, Fushimi S, Nagatani T, Kataoka Y, Nishizaki K, Sato Y, Ando M. The fine-needle aspiration cytology and clinical findings of Kikuchi-Fujimoto disease in pediatric patients: a retrospective clinical study. Acta Otolaryngol. 2022 Mar 2;1-5. doi: 10.1080/00016489.2022.2040744.

Tsumura M, Makihara S, Nishikori A, Gion Y, Morito T, Miyamoto S, Naito T, Uraguchi K, Oka A, Tachibana T, Orita Y, Kariya S, Okano M, Ando M, Sato Y. Clinicopathologic analysis of sinonasal inverted papilloma, with focus on human papillomavirus infection status. Diagnostics 2022, 12(2), 454; https://doi.org/10.3390/diagnostics12020454

Matsuhashi M, Nishida K, Sakamoto M, Gion Y, Yoshida A, Katsuyama T, Nakahara R, Nasu Y, Matsumoto Y, Sato Y, Ozaki T. CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Inflamm Res. 2022 Jan 22. doi: 10.1007/s00011-021-01537-z.